Trendous viralate
Greedy? The hilarious battle for COVID-19 rages on. The United States under President Donald Trump buys all Remdesivir COVID-19 drug and its subsequent three months of manufacturing.
The Trump administration says it has locked down nearly the entire supply of one of the only available anti-COVID-19 drugs from the manufacturer for the next several months.
Remdesivir is the first drug shown to help patients with COVID-19, though its impact is modest.
Hospitalized patients given the drug recovered four days faster than those given a placebo.
Preliminary results did not show that it saved lives, but the study is ongoing.
On Monday, the U.S. Department of Health and Human Services said it had gotten 500,000 treatment courses of the antiviral drug from the company that made it.
Gilead Sciences, a pharmaceutical company based in the United States, has ensured that all of its production for the month of July, as well as 90% of its production for the months of August and September.
“President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” HHS Secretary Alex Azar said.
This post was created with our nice and easy submission form. Create your post!
